PMA P010032S251

Device
Quattrode®; Octrode™; Penta™; Lamitrode™; Tripole™; TriCentrus™ Lead Extensions
Applicant
ABBOTT MEDICAL
PMA number
P010032
Supplement
S251
Product code
LGW
Decision date
2026-09-18
Classification
Neurology
Generic name
Stimulator, spinal-cord, totally implanted for pain relief
Approval order statement
1) optimization of the process parameter ranges of the injection molding equipment used in the manufacturing of the Bionate® 55D injection-molded portions at the stimulation and terminal ends of the Quattrode™; Octrode™; Penta™; Lamitrode™; Tripole™; and TriCentrus™ Leads and Lead Extensions at the Abbott manufacturing facility in Arecibo, Puerto Rico; and 2) qualification of a second injection molding machine of identical make, model, and configuration to the existing Nissei STX10 Machine at the Abbott manufacturing facility in Arecibo, Puerto Rico.

Current openFDA PMA Record#

Device
Quattrode®; Octrode™; Penta™; Lamitrode™; Tripole™; TriCentrus™ Lead Extensions
Applicant
ABBOTT MEDICAL
PMA number
P010032
Supplement
S251
Product code
LGW
Generic name
Stimulator, spinal-cord, totally implanted for pain relief
Decision date
2026-09-18
Decision code
APPR
Date received
2026-04-17
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
1) optimization of the process parameter ranges of the injection molding equipment used in the manufacturing of the Bionate® 55D injection-molded portions at the stimulation and terminal ends of the Quattrode™; Octrode™; Penta™; Lamitrode™; Tripole™; and TriCentrus™ Leads and Lead Extensions at the Abbott manufacturing facility in Arecibo, Puerto Rico; and 2) qualification of a second injection molding machine of identical make, model, and configuration to the existing Nissei STX10 Machine at the Abbott manufacturing facility in Arecibo, Puerto Rico.